IMDX

4.29

0.23% -0.010

Dopo l'orario di chiusura: 4.29

Insight Molecular Diagnostics Inc (IMDX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$4.30

Aprire:

$4.27

Volume 24 ore:

36,361

Relative Volume:

0.15

Capitalizzazione di mercato:

$140.39M

Reddito:

$1.95M

Utile/perdita netta:

$-47.84M

Rapporto P/E:

-2.8924

EPS:

-1.4832

Flusso di cassa netto:

$-27.46M

1 W Prestazione:

-0.23%

1M Prestazione:

-8.72%

6M Prestazione:

-28.62%

1 anno Prestazione:

+72.98%

Intervallo 1D:

$4.23

$4.32

Intervallo di 1 settimana:

$4.20

$4.54

Portata 52W:

$2.33

$8.51

Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile

Nome

Insight Molecular Diagnostics Inc

Settore

Healthcare (1082)

Industria

Diagnostics & Research (50)

Telefono

949-409-7600

Indirizzo

2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE

Dipendente

Cinguettio

Prossima data di guadagno

2026-08-10

Ultimi documenti SEC

IMDX's Discussions on Twitter

Compare IMDX vs TMO, DHR, NTRA, A, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IMDX Insight Molecular Diagnostics Inc	4.29	140.71M	1.95M	-47.84M	-27.46M	-1.4832
TMO Thermo Fisher Scientific Inc	630.70	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	215.68	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	338.70	46.82B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	157.69	44.14B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.38	42.15B	16.63B	1.39B	2.12B	8.0674

Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-03-28	Iniziato	Lake Street	Buy
2022-05-24	Downgrade	Stephens	Overweight → Equal-Weight
2022-03-14	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2022-01-07	Iniziato	Stephens	Overweight
2022-01-06	Ripresa	Piper Sandler	Overweight
2021-03-17	Ripresa	Needham	Buy
2021-01-07	Aggiornamento	The Benchmark Company	Speculative Buy → Buy
2020-12-16	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-11-30	Iniziato	BTIG Research	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-07-30	Reiterato	The Benchmark Company	Speculative Buy
2020-07-01	Downgrade	Piper Sandler	Overweight → Neutral
2020-06-30	Downgrade	Chardan Capital Markets	Buy → Neutral
2020-06-02	Iniziato	Needham	Buy
2019-02-13	Iniziato	Piper Jaffray	Overweight
2019-01-29	Aggiornamento	Janney	Neutral → Buy
2018-12-19	Ripresa	Lake Street	Buy

Mostra tutto

Insight Molecular Diagnostics Inc Borsa (IMDX) Ultime notizie

Aug 19, 2026

Insight (IMDX) Price: Adds 2.34% to Close at $4.38 in Latest Trading; Price Levels: the $4.16 to $4.60 Range Remains in Focus in the Current UpdateTriangle Correction - vinanet.vn

Aug 19, 2026

Insight (IMDX) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in Latest Trading; Market Read: The Stock Gains 0.23% at the CloseEarnings Surprise Score - vinanet.vn

Aug 19, 2026

Aug 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 18, 2026

Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Aug 18, 2026

IMDX Reiterated by Needham -- Price Target Maintained at $9.00 - GuruFocus

Aug 18, 2026

Needham Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Aug 18, 2026

Aug 17, 2026

Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 17, 2026

Insight Molecular Diagnostics advances heart tr... - Pluang

Aug 17, 2026

Aug 15, 2026